Adverse reactions induced by MDT/WHO (Rifampicin+Clofazimine+Dapsone) and ROM (Rifampicin+Ofloxacin+Minocycline) regimens used in the treatment of leprosy: a cohort study in a National Reference Center in Brazil
Background: Recommended standard treatment for leprosy is multidrugtherapy (MDT/WHO), consisting Rifampicin+Dapsone+Clofazimine. Other medications are recommended in cases of resistance, adverse reactions and intolerances, including ROM regimen, Rifampicin+Ofloxacin+Minocycline. Therefore, pharmacov...
Saved in:
Main Authors: | Isadora Costa Celestino (Author), Douglas Eulalio Antunes (Author), Diogo Fernandes Santos (Author), Victor Lemos Gimenes (Author), Fabiane Mian de Souza (Author), Isabela Maria Bernardes Goulart (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generalized granuloma annulare treated with monthly rifampicin, ofloxacin, and minocycline combination therapy
by: Shilpa Garg, et al.
Published: (2013) -
Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro
by: Ronald Anderson, et al.
Published: (2018) -
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
by: Sedona Sweeney, et al.
Published: (2022) -
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
by: Sedona Sweeney, et al.
Published: (2022) -
Rifampicin induced thrombocytopenia
by: Das Sudip, et al.
Published: (2006)